U.S. equities were little changed on Monday, with the S&P 500 slipping 0.01% to 6,449.26, the Dow Jones Industrial Average easing 0.08% to 44,912.38, and the Nasdaq Composite edging 0.08% higher to 21,641.14. Trading volumes were muted as investors positioned ahead of Wednesday’s release of Federal Reserve policy-meeting minutes and the central-bankers’ gathering in Jackson Hole later in the week, events expected to offer fresh guidance on the interest-rate outlook. Among individual movers, Novo Nordisk gained almost 6% after the U.S. Food and Drug Administration granted accelerated approval for the company’s obesity drug Wegovy to treat a severe liver disease, providing a bright spot in an otherwise subdued session.